Skip to main content
Clinical Trials/DRKS00013159
DRKS00013159
Completed
Not Applicable

Pregnancy outcome after first trimester exposure to fosfomycin - a prospective cohort study - fosfomycin in pregnancy

Pharmakovigilanzzentrum Embryonaltoxikologie Charité-Universitätsmedizin0 sites608 target enrollmentOctober 13, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Q89.9
Sponsor
Pharmakovigilanzzentrum Embryonaltoxikologie Charité-Universitätsmedizin
Enrollment
608
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2017
End Date
March 1, 2019
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Pharmakovigilanzzentrum Embryonaltoxikologie Charité-Universitätsmedizin

Eligibility Criteria

Inclusion Criteria

  • Prospectively ascertained pregnancies, which means neither the outcome of pregnancy nor prenatal pathologic findings are known at date of recruitment.
  • Study group: fosfomycin exposure during first trimester. Control group: Patients without exposure of the study drug

Exclusion Criteria

  • Exclusion criteria (applies for the exposed and the comparison group): Exclusion of cases with maternal exposure considered as potent teratogens or fetotoxicants or malignant diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Pregnancy outcome after first-trimester exposure to metformin: the experience of the Berlin institute for clinical teratology and drug risk assessment in pregnancycongenital malformations/spontaneous abortions after intrauterine metformin exposureQ89.9O03Congenital malformation, unspecifiedSpontaneous abortion
DRKS00007621Pharmakovigilanz- und Beratungszentrum für EmbryonaltoxikologieCharité - Universitätsmedizin Berlin1,500
Enrolling By Invitation
Not Applicable
Pregnancy outcome after 1st trimester exposure to statins - an evaluation based on the Embryotox cohort databaseQ89.9O03P95Congenital malformation, unspecifiedSpontaneous abortionFetal death of unspecified cause
DRKS00029177Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum,840
Not yet recruiting
Not Applicable
Effect of bleeding in pregnancy on pregnancy outcomeHealth Condition 1: O200- Threatened abortionHealth Condition 2: O200- Threatened abortion
CTRI/2022/11/046990Dr Kanchan Dalmia
Not yet recruiting
Not Applicable
Study the association between motherâ??s first trimester characteristics, ultrasound findings ,blood investigations with pregnancy complicationsHealth Condition 1: O098- Supervision of other high risk pregnancies
CTRI/2021/03/032233Kasturba medical college Manipal
Completed
Not Applicable
Prediction of adverse pregnancy outcomes following induction of labourPregnancy and childbirthPregnancy and Childbirth
ISRCTN10984408Medway NHS Foundation Trust1,000